Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Malignant T-cell-amplified sequence 1 | ||
Ligand | BDBM403040 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | MTT assay | ||
EC50 | <20.0±n/a nM | ||
Citation | Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL Heterocyclic inhibitors of monocarboxylate transporter US Patent US10329303 Publication Date 6/25/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Malignant T-cell-amplified sequence 1 | |||
Name: | Malignant T-cell-amplified sequence 1 | ||
Synonyms: | MCT-1 | MCT1 | MCTS1 | MCTS1_HUMAN | Multiple copies T-cell malignancies | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 20563.62 | ||
Organism: | Homo sapiens (human) | ||
Description: | n/a | ||
Residue: | 181 | ||
Sequence: |
| ||
BDBM403040 | |||
n/a | |||
Name | BDBM403040 | ||
Synonyms: | US10329303, Example 6 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H26F2N4O3S | ||
Mol. Mass. | 488.55 | ||
SMILES | CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(CO)c(F)cc3F)c2c(=O)n(C)c1=O |(-4.16,-6.29,;-4.16,-4.75,;-5.5,-3.98,;-2.83,-3.98,;-2.83,-2.44,;-1.49,-1.67,;-.03,-2.15,;.88,-.9,;2.42,-.9,;3.19,-2.24,;2.71,-3.7,;1.38,-4.47,;3.96,-4.61,;5.2,-3.7,;4.73,-2.24,;5.5,-.9,;-.03,.34,;.37,1.83,;1.86,2.23,;2.25,3.72,;3.74,4.12,;4.83,3.03,;1.17,4.81,;1.56,6.29,;-.32,4.41,;-.72,2.92,;-2.21,3.32,;-1.49,-.13,;-2.83,.64,;-2.83,2.18,;-4.16,-.13,;-5.5,.64,;-4.16,-1.67,;-5.5,-2.44,)| | ||
Structure |